Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06841510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

Study acronym: GENOSS SES
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 16, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment target: 1116 to 1118 Primary and study completion dates: Sep 30, 2025 to Nov 30, 2025v2 Show 1 more changeShow less
    • Primary and study completion dates: Sep 30, 2025 to Nov 30, 2025
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Efficacy and Safety of GENOSS SES in patients with coronary artery disease
Trial Details
NCT Number NCT06841510
Lead Sponsor Genoss Co., Ltd.
Conditions Coronary Arterial Disease (CAD)
Enrollment 1,118 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov